Cancer Conversations™ in Melanoma: Discussion and Debate on How New Data Are Changing Current Therapeutic Algorithms

Gain insights into the rationale and evidence for neoadjuvant therapy in melanoma in this expert commentary.

Jeffrey S. Weber, MD, PhD
Program Director Released: July 15, 2021

Download these slides from a live webinar to learn more about how the latest data are changing the treatment landscape for advanced melanoma in both the adjuvant and metastatic setting.

Jeffrey S. Weber, MD, PhD
Program Director Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Released: September 7, 2021

Download this summary slideset from a live webinar to learn more about how new data and emerging treatment options are changing the therapeutic algorithm in melanoma.

Jeffrey S. Weber, MD, PhD
Program Director Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Released: September 10, 2021

Watch this on-demand webcast of a live CCO webinar to hear a panel of experts discuss the changing treatment landscape in melanoma.

Jeffrey S. Weber, MD, PhD
Program Director Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: September 29, 2021 Expired: September 28, 2022

In this podcast episode, Jeffrey S. Weber, MD, PhD; Allison Betof Warner, MD, PhD; and Hussein Tawbi, MD, PhD, discuss the key data on adjuvant and neoadjuvant therapy and review current and emerging treatment options for metastatic disease.

Jeffrey S. Weber, MD, PhD
Program Director Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Released: September 28, 2021

Download this summary slideset to accompany a podcast featuring expert insight on the current treatment landscape in melanoma and how recent evidence on emerging therapies and strategies is poised to alter current therapeutic algorithms.

Jeffrey S. Weber, MD, PhD
Program Director Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Released: September 28, 2021